Physician profile
Daniel Khaimov
NPI 1750545307
$5,251.25
in general payments reported to CMS, 2019-2025
12 companies · $158 in 2025
The $158 reported for 2025 was more than what 76% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,829 · 2020: $94.58 · 2021: $250 · 2022: $278 · 2023: $303 · 2024: $2,339 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,521 · Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,521.32 |
| Food and Beverage | $1,278.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,177.64 | 2024 | Evoke |
| Angiodynamics, INC. | $1,405.08 | 2019 | |
| Medtronic, INC. | $759.24 | 2021-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $254.92 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $136.83 | 2019 | |
| Globus Medical, INC. | $115.67 | 2025 | Senza |
| Abbvie INC. | $114.62 | 2024 | |
| Lundbeck LLC | $59.76 | 2019-2020 | |
| Abbott Laboratories | $58.11 | 2021 | |
| Medtronic USA, INC. | $57.43 | 2020 | |
| Allergan, INC. | $56.89 | 2019 | |
| Nevro Corp. | $55.06 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Khaimov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.